Chronic glucocorticoid management in neuromuscular disease: A survey of neuromuscular neurologists.

There is substantial variability in the management of GC adverse effects among neuromuscular neurologists, often not corresponding to limited published literature. Our results support the need for improved education and neurology-specific guidelines to help standardize practice and improve and prevent complications.